|
TW201639852A
(zh)
|
2008-12-09 |
2016-11-16 |
吉李德科學股份有限公司 |
用於製備可用作類鐸受體調節劑之化合物的中間體化合物
|
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
|
MX2012015097A
(es)
|
2010-07-02 |
2013-05-28 |
Gilead Sciences Inc |
Derivados de acido naft-2-ilacetico para tratar sida.
|
|
US9296758B2
(en)
|
2010-07-02 |
2016-03-29 |
Gilead Sciences, Inc. |
2-quinolinyl-acetic acid derivatives as HIV antiviral compounds
|
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
TW201302760A
(zh)
*
|
2011-04-04 |
2013-01-16 |
Gilead Sciences Inc |
製備ｈｉｖ整合酶抑制劑之方法
|
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
ES2742261T3
(es)
|
2011-04-15 |
2020-02-13 |
Hivih |
Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos
|
|
EP3181555B1
(en)
|
2011-04-21 |
2018-11-28 |
Gilead Sciences, Inc. |
Benzothiazole compounds and their pharmaceutical use
|
|
ES2553449T3
(es)
|
2011-07-06 |
2015-12-09 |
Gilead Sciences, Inc. |
Compuestos para el tratamiento de VIH
|
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CN102952069B
(zh)
*
|
2011-08-19 |
2014-12-17 |
中国科学技术大学 |
一种化合物及其制备方法和应用
|
|
AP2014007595A0
(en)
*
|
2011-09-30 |
2014-04-30 |
Kineta Inc |
Anti-viral compounds
|
|
EP2772480B2
(en)
|
2011-10-25 |
2020-12-09 |
Shionogi & Co., Ltd. |
Hiv replication inhibitor
|
|
CN104066732B
(zh)
|
2011-11-15 |
2016-04-13 |
韩国化学硏究院 |
新型抗病毒吡咯并吡啶衍生物及其制备方法
|
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
|
US8629276B2
(en)
|
2012-02-15 |
2014-01-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
MD20140063A2
(ro)
|
2012-04-20 |
2014-12-31 |
Gilead Sciences, Inc. |
Derivaţi de acid benzotiazol-6-il acetic şi utilizarea acestora pentru tratarea unei infecţii HIV
|
|
US8906929B2
(en)
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2716639A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2716632A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2719685A1
(en)
*
|
2012-10-11 |
2014-04-16 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
NZ631762A
(en)
|
2013-01-09 |
2017-02-24 |
Gilead Sciences Inc |
5-membered heteroaryls and their use as antiviral agents
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
NZ727792A
(en)
|
2013-01-09 |
2018-04-27 |
Gilead Sciences Inc |
Therapeutic compounds
|
|
TW201441197A
(zh)
*
|
2013-01-31 |
2014-11-01 |
Shionogi & Co |
Ｈｉｖ複製抑制劑
|
|
TWI694071B
(zh)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
|
|
WO2014164428A1
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
ES2623777T3
(es)
*
|
2013-03-13 |
2017-07-12 |
VIIV Healthcare UK (No.5) Limited |
Inhibidores de la replicación del virus de la inmunodeficiencia humana
|
|
CN105189511B
(zh)
|
2013-03-13 |
2017-05-24 |
百时美施贵宝公司 |
人免疫缺陷病毒复制的抑制剂
|
|
ES2623904T3
(es)
*
|
2013-03-14 |
2017-07-12 |
VIIV Healthcare UK (No.5) Limited |
Inhibidores de la replicación del virus de la inmunodeficiencia humana
|
|
EP2970297A1
(en)
|
2013-03-14 |
2016-01-20 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2821082A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
PL3252058T3
(pl)
|
2013-07-12 |
2021-07-19 |
Gilead Sciences, Inc. |
Policykliczne związki karbamoilopirydonowe i ich zastosowanie do leczenia infekcji hiv
|
|
NO2865735T3
(cg-RX-API-DMAC10.html)
|
2013-07-12 |
2018-07-21 |
|
|
|
KR20160074473A
(ko)
|
2013-09-05 |
2016-06-28 |
다우 아그로사이언시즈 엘엘씨 |
보릴화 아렌의 제조 방법
|
|
US9944656B2
(en)
|
2014-02-12 |
2018-04-17 |
VIIV Healthcare UK (No.5) Limited |
Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
|
|
US9409922B2
(en)
*
|
2014-02-18 |
2016-08-09 |
Bristol-Myers Squibb Company |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
PT3107913T
(pt)
|
2014-02-19 |
2018-09-28 |
Viiv Healthcare Uk No 5 Ltd |
Inibidores da replicação do vírus da imunodeficiência humana
|
|
US9193720B2
(en)
|
2014-02-20 |
2015-11-24 |
Bristol-Myers Squibb Company |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
PT3116880T
(pt)
|
2014-02-20 |
2018-05-10 |
Viiv Healthcare Uk No 5 Ltd |
Macrociclos de ácido piridin-3-il acético como inibidores da replicação do vírus da imunodeficiência humana
|
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
EP3144311A4
(en)
|
2014-05-16 |
2018-01-03 |
Shionogi & Co., Ltd. |
Tricyclic heterocyclic derivative having hiv replication-inhibiting effect
|
|
TW201625354A
(zh)
|
2014-06-16 |
2016-07-16 |
陶氏農業科學公司 |
用於製備氧硼基化芳烴之方法
|
|
NO2717902T3
(cg-RX-API-DMAC10.html)
|
2014-06-20 |
2018-06-23 |
|
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
JP2017521428A
(ja)
|
2014-07-08 |
2017-08-03 |
ヴィーブ ヘルスケア ユーケー リミテッド |
ウイルス感染症の治療に使用するためのイソインドリン誘導体
|
|
NZ728072A
(en)
|
2014-07-11 |
2018-06-29 |
Gilead Sciences Inc |
Modulators of toll-like receptors for the treatment of hiv
|
|
AU2015293578B2
(en)
*
|
2014-07-21 |
2017-10-05 |
Viiv Healthcare Uk Limited |
Phenyl and tertbutylacetic acid substituted pyridinones having anti-HIV effects
|
|
RU2017107715A
(ru)
*
|
2014-08-27 |
2018-09-27 |
ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД |
Производные имидазо[1,2-a]пиридина для применения в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
US20160067255A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
|
CA2960436C
(en)
|
2014-09-16 |
2021-01-05 |
Gilead Sciences, Inc. |
Solid forms of a toll-like receptor modulator
|
|
TWI738321B
(zh)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
TW202237569A
(zh)
|
2014-12-24 |
2022-10-01 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
|
AU2015371257B2
(en)
|
2014-12-24 |
2018-09-06 |
Gilead Sciences, Inc. |
Isoquinoline compounds for the treatment of HIV
|
|
MX2017008520A
(es)
|
2014-12-24 |
2018-03-01 |
Gilead Sciences Inc |
Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih).
|
|
MY188211A
(en)
|
2015-03-04 |
2021-11-24 |
Gilead Sciences Inc |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
ES2718410T3
(es)
|
2015-04-02 |
2019-07-01 |
Gilead Sciences Inc |
Compuestos de carbamoilpiridonas policíclicos y su utilización farmacéutica
|
|
MX2017015256A
(es)
|
2015-05-29 |
2018-02-19 |
Shionogi & Co |
Derivados triciclicos que contienen nitrogeno que tienen actividad inhibidora de la replicacion del virus de inmunodeficiencia adquirida (vih).
|
|
BR112018000177A2
(pt)
*
|
2015-07-06 |
2018-09-04 |
Viiv Healthcare Uk No 5 Ltd |
composto, composição, e, método para tratar a infecção pelo hiv.
|
|
AU2016290151A1
(en)
*
|
2015-07-08 |
2018-01-18 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-YL acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
RU2018103031A
(ru)
*
|
2015-07-09 |
2019-08-09 |
ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД |
Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
RU2018103032A
(ru)
*
|
2015-07-09 |
2019-08-09 |
ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД |
Производные пиридин-3-ил-уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
CN108137532A
(zh)
*
|
2015-08-07 |
2018-06-08 |
Viiv保健英国第五有限公司 |
作为人免疫缺陷病毒复制的抑制剂的吡啶-3-基乙酸衍生物
|
|
AU2016305338A1
(en)
|
2015-08-10 |
2018-03-01 |
VIIV Healthcare UK (No.5) Limited |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
TWI657086B
(zh)
*
|
2015-08-11 |
2019-04-21 |
英商Viiv醫療保健英國(No.5)有限公司 |
做為人類免疫缺陷病毒複製抑制劑之５－（ｎ－苯甲基四氫異喹啉－６－基）吡啶－３－基乙酸衍生物
|
|
TW201718537A
(zh)
|
2015-08-12 |
2017-06-01 |
Ｖｉｉｖ醫療保健英國（Ｎｏ．５）有限公司 |
做為人類免疫缺陷病毒複製抑制劑之吡啶－３－基乙酸衍生物
|
|
EP3334723B1
(en)
|
2015-08-12 |
2019-09-18 |
VIIV Healthcare UK (No.5) Limited |
5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
US10214516B2
(en)
|
2015-08-12 |
2019-02-26 |
VIIV Healthcare UK (No.5) Limited |
5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
JP2018523695A
(ja)
*
|
2015-08-20 |
2018-08-23 |
ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド |
ヒト免疫不全ウイルス複製の阻害剤としてのピリジン−３−イル酢酸誘導体
|
|
JP2018525412A
(ja)
|
2015-08-26 |
2018-09-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
重水素化トール様受容体調節因子
|
|
AU2016322763A1
(en)
|
2015-09-15 |
2018-04-19 |
Gilead Sciences, Inc. |
Modulators of toll-like recptors for the treatment of HIV
|
|
ES2797900T3
(es)
|
2015-09-30 |
2020-12-04 |
Gilead Sciences Inc |
Compuestos y combinaciones para el tratamiento del VIH
|
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
|
SG10202004618TA
(en)
|
2015-11-19 |
2020-06-29 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
WO2017093937A1
(en)
|
2015-12-04 |
2017-06-08 |
Viiv Healthcare Uk Limited |
Isoindoline derivatives
|
|
EA202091898A1
(ru)
|
2015-12-15 |
2021-06-22 |
Джилид Сайэнс, Инк. |
Антитела, нейтрализующие вирус иммунодефицита человека
|
|
US20170174671A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SI3394033T1
(sl)
|
2015-12-22 |
2021-03-31 |
Incyte Corporation |
Heterociklične spojine kot imunomodulatorji
|
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
US10407410B2
(en)
|
2016-05-11 |
2019-09-10 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
EP3455217A1
(en)
|
2016-05-11 |
2019-03-20 |
ViiV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
US20190152957A1
(en)
|
2016-05-11 |
2019-05-23 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
MA45116A
(fr)
|
2016-05-26 |
2021-06-02 |
Incyte Corp |
Composés hétérocycliques comme immunomodulateurs
|
|
ES2927984T3
(es)
|
2016-06-20 |
2022-11-14 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
CN109803651B
(zh)
|
2016-06-27 |
2022-05-31 |
凯莫森特里克斯股份有限公司 |
免疫调节剂化合物
|
|
CN107573332B
(zh)
*
|
2016-07-05 |
2022-04-19 |
广州再极医药科技有限公司 |
芳香乙炔或芳香乙烯类化合物、其中间体、制备方法、药物组合物及应用
|
|
ES2930092T3
(es)
|
2016-07-14 |
2022-12-07 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
PE20211427A1
(es)
|
2016-08-19 |
2021-08-03 |
Gilead Sciences Inc |
Compuestos terapeuticos utiles para el tratamiento profilatico o terapeutico de una infeccion por el virus del vih
|
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018042331A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
WO2018042332A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
MA46093A
(fr)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Composés modulateurs du recepteur de type toll
|
|
WO2018051250A1
(en)
|
2016-09-14 |
2018-03-22 |
Viiv Healthcare Company |
Combination comprising tenofovir alafenamide, bictegravir and 3tc
|
|
EP3519409B1
(en)
|
2016-09-28 |
2024-09-18 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
|
|
WO2018081292A1
(en)
|
2016-10-27 |
2018-05-03 |
Gilead Sciences, Inc. |
Crystalline forms of darunavir free base, hydrate, solvates and salts
|
|
ES2929193T3
(es)
|
2016-12-22 |
2022-11-25 |
Incyte Corp |
Derivados de tetrahidro imidazo[4,5-c]piridina como inductores de la internalización de PD-L1
|
|
MX391981B
(es)
|
2016-12-22 |
2025-03-21 |
Incyte Corp |
Derivados de benzooxazol como inmunomoduladores.
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
EP3558963B1
(en)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
WO2018127800A1
(en)
|
2017-01-03 |
2018-07-12 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
US20200016136A1
(en)
|
2017-01-03 |
2020-01-16 |
Viiv Healthcare Uk (No. 5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
AR110768A1
(es)
|
2017-01-31 |
2019-05-02 |
Gilead Sciences Inc |
Formas cristalinas de tenofovir alafenamida
|
|
JOP20180009A1
(ar)
|
2017-02-06 |
2019-01-30 |
Gilead Sciences Inc |
مركبات مثبط فيروس hiv
|
|
IL271148B
(en)
*
|
2017-06-14 |
2022-08-01 |
Bayer Ag |
Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
|
|
AU2018290228B2
(en)
|
2017-06-21 |
2021-07-01 |
Gilead Sciences, Inc. |
Multispecific antibodies that target HIV gp120 and CD3
|
|
RU2755710C2
(ru)
|
2017-06-30 |
2021-09-20 |
Вайв Хелткер Компани |
Комбинация, ее применение и способы лечения с использованием указанной комбинации
|
|
WO2019023575A1
(en)
|
2017-07-28 |
2019-01-31 |
Chemocentryx, Inc. |
IMMUNOMODULATORY COMPOUNDS
|
|
ES2892402T3
(es)
|
2017-08-01 |
2022-02-04 |
Gilead Sciences Inc |
Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
|
|
JP7198269B2
(ja)
|
2017-08-08 |
2022-12-28 |
ケモセントリックス，インコーポレイティド |
大員環免疫調節剤
|
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
|
AR112413A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas sólidas de un inhibidor de la cápside del vih
|
|
JP6934562B2
(ja)
|
2017-08-22 |
2021-09-15 |
ギリアード サイエンシーズ， インコーポレイテッド |
治療用複素環式化合物
|
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
|
WO2019084020A1
(en)
|
2017-10-24 |
2019-05-02 |
Gilead Sciences, Inc. |
METHODS OF TREATING PATIENTS CO-INFECTED BY A VIRUS AND TUBERCULOSIS
|
|
AU2018392212B9
(en)
|
2017-12-20 |
2021-03-18 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
|
|
WO2019123340A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
AU2018398887B2
(en)
|
2017-12-29 |
2024-03-14 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
|
WO2019144015A1
(en)
|
2018-01-19 |
2019-07-25 |
Gilead Sciences, Inc. |
Metabolites of bictegravir
|
|
EP3752495B1
(en)
|
2018-02-15 |
2023-07-19 |
Gilead Sciences, Inc. |
Pyridine derivatives and their use for treating hiv infection
|
|
TWI823164B
(zh)
|
2018-02-16 |
2023-11-21 |
美商基利科學股份有限公司 |
用於製備有療效化合物之方法及中間物
|
|
EP3755311B1
(en)
|
2018-02-22 |
2026-01-28 |
ChemoCentryx, Inc. |
Indane-amines as pd-l1 antagonists
|
|
SMT202300065T1
(it)
|
2018-03-30 |
2023-05-12 |
Incyte Corp |
Composti eterociclici come immunomodulatori
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
PL3790877T3
(pl)
|
2018-05-11 |
2023-06-12 |
Incyte Corporation |
Pochodne tetrahydroimidazo[4,5-c]pirydyny jako immunomodulatory pd-l1
|
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
CA3102859A1
(en)
|
2018-07-03 |
2020-01-09 |
Gilead Sciences, Inc. |
Antibodies that target hiv gp120 and methods of use
|
|
WO2020010200A1
(en)
|
2018-07-06 |
2020-01-09 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
US11186579B2
(en)
|
2018-07-06 |
2021-11-30 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
CA3103522C
(en)
|
2018-07-16 |
2023-11-21 |
Gilead Sciences, Inc. |
Capsid inhibitors for the treatment of hiv
|
|
TWI766172B
(zh)
|
2018-07-30 |
2022-06-01 |
美商基利科學股份有限公司 |
抗hiv化合物
|
|
CN112996517A
(zh)
|
2018-09-19 |
2021-06-18 |
吉利德科学公司 |
预防hiv的整合酶抑制剂
|
|
US11179397B2
(en)
|
2018-10-03 |
2021-11-23 |
Gilead Sciences, Inc. |
Imidazopyrimidine derivatives
|
|
CR20210215A
(es)
|
2018-10-31 |
2021-06-17 |
Gilead Sciences Inc |
Compuestos de 6-azabencimidazol sustituidos como inhibidores de hpk1
|
|
CN117105933A
(zh)
|
2018-10-31 |
2023-11-24 |
吉利德科学公司 |
具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物
|
|
WO2020176505A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
WO2020176510A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
CA3129022C
(en)
|
2019-03-07 |
2023-08-01 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
KR102808642B1
(ko)
|
2019-03-07 |
2025-05-14 |
인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. |
3'3'-사이클릭 다이뉴클레오티드 및 이의 프로드럭
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
CN119462659A
(zh)
|
2019-03-22 |
2025-02-18 |
吉利德科学公司 |
桥连三环氨基甲酰基吡啶酮化合物及其药学用途
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US20200347036A1
(en)
|
2019-04-17 |
2020-11-05 |
Gilead Sciences, Inc. |
Solid forms of an hiv protease inhibitor
|
|
TWI751517B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202104210A
(zh)
|
2019-04-17 |
2021-02-01 |
美商基利科學股份有限公司 |
Hiv蛋白酶抑制劑
|
|
TWI762925B
(zh)
|
2019-05-21 |
2022-05-01 |
美商基利科學股份有限公司 |
鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法
|
|
US11453681B2
(en)
|
2019-05-23 |
2022-09-27 |
Gilead Sciences, Inc. |
Substituted eneoxindoles and uses thereof
|
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
CR20210687A
(es)
|
2019-06-25 |
2022-03-03 |
Gilead Sciences Inc |
PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
|
|
WO2021007386A1
(en)
|
2019-07-10 |
2021-01-14 |
Chemocentryx, Inc. |
Indanes as pd-l1 inhibitors
|
|
CN120775062A
(zh)
|
2019-07-16 |
2025-10-14 |
吉利德科学公司 |
Hiv疫苗及其制备和使用方法
|
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
WO2021030162A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
|
EP4017476A1
(en)
|
2019-08-19 |
2022-06-29 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
IL291471B2
(en)
|
2019-09-30 |
2025-04-01 |
Incyte Corp |
Pyrimido[3,2–D]pyrimidine compounds as immunomodulators
|
|
CN114829366A
(zh)
|
2019-11-11 |
2022-07-29 |
因赛特公司 |
Pd-1/pd-l1抑制剂的盐及结晶形式
|
|
KR20220106165A
(ko)
|
2019-11-26 |
2022-07-28 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 예방을 위한 캡시드 억제제
|
|
PL4081305T3
(pl)
|
2019-12-24 |
2025-02-10 |
Carna Biosciences, Inc. |
Związki modulujące kinazę diacyloglicerolową
|
|
AU2021225809B2
(en)
|
2020-02-24 |
2023-08-24 |
Gilead Sciences, Inc. |
Tetracyclic compounds for treating HIV infection
|
|
EP4121437A1
(en)
|
2020-03-20 |
2023-01-25 |
Gilead Sciences, Inc. |
Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
|
WO2021236944A1
(en)
|
2020-05-21 |
2021-11-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising bictegravir
|
|
KR20230027275A
(ko)
|
2020-06-25 |
2023-02-27 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 치료용 캡시드 저해제
|
|
JP7712352B2
(ja)
|
2020-08-07 |
2025-07-23 |
ギリアード サイエンシーズ， インコーポレイテッド |
ホスホンアミドヌクレオチド類似体のプロドラッグ及びその薬学的使用
|
|
JP7691494B2
(ja)
|
2020-09-30 |
2025-06-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
架橋三環式カルバモイルピリドン化合物及びその使用
|
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
US11866434B2
(en)
|
2020-11-06 |
2024-01-09 |
Incyte Corporation |
Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
|
|
TW202233615A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
Ｐｄ—１／ｐｄ—ｌ１抑制劑之結晶形式
|
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
|
KR20230107288A
(ko)
|
2020-11-11 |
2023-07-14 |
길리애드 사이언시즈, 인코포레이티드 |
gp120 CD4 결합 부위-지향 항체를 이용한 요법에 감수성인 HIV 환자를 식별하는 방법
|
|
HRP20231654T2
(hr)
|
2021-01-19 |
2025-01-03 |
Gilead Sciences, Inc. |
Supstituirani spojevi piridotriazina i njihove uporabe
|
|
US20220389394A1
(en)
|
2021-05-18 |
2022-12-08 |
Gilead Sciences, Inc. |
METHODS OF USING FLT3L-Fc FUSION PROTEINS
|
|
JP7686086B2
(ja)
|
2021-06-23 |
2025-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリエルコール（ｄｉａｃｙｌｇｌｙｅｒｃｏｌ）キナーゼ調節化合物
|
|
EP4359411A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2022271684A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CN117396478A
(zh)
|
2021-06-23 |
2024-01-12 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
WO2023050007A1
(en)
*
|
2021-09-29 |
2023-04-06 |
Repare Therapeutics Inc. |
N-(5-substituted-[(1,3,4-thiadiazolyl) or (thiazolyl)])(substituted)carboxamide compounds and use thereof for inhibiting human polymerase theta
|
|
FI4445900T3
(fi)
|
2021-12-03 |
2025-08-05 |
Gilead Sciences Inc |
Terapeuttisia yhdisteitä hiv-virusinfektiota varten
|
|
TW202342448A
(zh)
|
2021-12-03 |
2023-11-01 |
美商基利科學股份有限公司 |
用於ｈｉｖ病毒感染之治療性化合物
|
|
JP7736929B2
(ja)
|
2021-12-03 |
2025-09-09 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖウイルス感染症のための治療化合物
|
|
TWI856796B
(zh)
|
2022-04-06 |
2024-09-21 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
WO2024006982A1
(en)
|
2022-07-01 |
2024-01-04 |
Gilead Sciences, Inc. |
Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
|
|
CN119677546A
(zh)
|
2022-07-12 |
2025-03-21 |
吉利德科学公司 |
Hiv免疫原性多肽和疫苗及其用途
|
|
EP4577242A1
(en)
|
2022-08-26 |
2025-07-02 |
Gilead Sciences, Inc. |
Dosing and scheduling regimen for broadly neutralizing antibodies
|
|
AU2023352129A1
(en)
*
|
2022-09-29 |
2025-05-01 |
Repare Therapeutics Inc. |
N-(5-substituted-[(1,3,4-thiadiazolyl) or (1,3-thiazolyl)](substituted)carboxamide compounds, pharmaceutical compositions, and methods of preparing the amide compounds and of their use
|
|
US20240226130A1
(en)
|
2022-10-04 |
2024-07-11 |
Gilead Sciences, Inc. |
4'-thionucleoside analogues and their pharmaceutical use
|
|
AU2024259111A1
(en)
|
2023-04-19 |
2025-10-16 |
Gilead Sciences, Inc. |
Dosing regimen of capsid inhibitor
|
|
US20250042926A1
(en)
|
2023-05-31 |
2025-02-06 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv
|
|
US20250051375A1
(en)
|
2023-05-31 |
2025-02-13 |
Gilead Sciences, Inc. |
Anti-hiv compounds
|
|
US20250011352A1
(en)
|
2023-05-31 |
2025-01-09 |
Gilead Sciences, Inc. |
Solid forms
|
|
WO2025029247A1
(en)
|
2023-07-28 |
2025-02-06 |
Gilead Sciences, Inc. |
Weekly regimen of lenacapavir for the treatment and prevention of hiv
|
|
WO2025042394A1
(en)
|
2023-08-23 |
2025-02-27 |
Gilead Sciences, Inc. |
Dosing regimen of hiv capsid inhibitor
|
|
WO2025076542A1
(en)
|
2023-10-05 |
2025-04-10 |
Jones R Brad |
Atovaquone as an ros inducer for use in the elimination of hiv-infected t-cells
|
|
WO2025080850A1
(en)
|
2023-10-11 |
2025-04-17 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
TW202515549A
(zh)
|
2023-10-11 |
2025-04-16 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
WO2025080863A1
(en)
|
2023-10-11 |
2025-04-17 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
WO2025137245A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
WO2025184452A1
(en)
|
2024-03-01 |
2025-09-04 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
WO2025184609A1
(en)
|
2024-03-01 |
2025-09-04 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
US20250296932A1
(en)
|
2024-03-01 |
2025-09-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|
|
US20250326779A1
(en)
|
2024-04-03 |
2025-10-23 |
Gilead Sciences, Inc. |
Anti-hiv compounds
|
|
US20260007683A1
(en)
|
2024-06-14 |
2026-01-08 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|